Sandra Laufer

Dr. Sandra Laufer is a Researcher at the III. Department of Medicine within the University Medical Center Hamburg-Eppendorf (UKE). Her work intersects cardiovascular and renal pathophysiology, stem cell technology, and molecular disease modeling. She maintains active collaborations across multiple research groups, contributing significantly to studies involving induced pluripotent stem cells (iPSCs), organoid systems, and genetic mechanisms of cardiac/kidney disorders.

Research Focus: Dr. Laufer's investigations span:

• Cardiovascular Pathobiology: Hypertrophic/dilated cardiomyopathy mechanisms, sarcomere gene mutations, calcium handling
• Regenerative Medicine: iPSC differentiation protocols, engineered heart tissue, disease modeling
• Molecular Mechanisms: Mitochondrial dynamics, epigenetic regulation (DNA methylation), ubiquitin ligase functions
• Renal Pathophysiology: Podocyte injury in Fabry nephropathy, multi-omics organoid characterization

Publication Trends: Her recent work (2020-2024) demonstrates:

• Expanding focus on mitochondrial physiology and redox signaling in stem cells
• Advanced genome editing applications (CRISPR/Cas9) for cardiac disease modeling
• Integration of multi-omics approaches with 3D organoid systems
• Translation of basic findings toward therapeutic strategies for genetic cardiomyopathies